Skip to main content
. 2022 Mar 10;186(6):607–617. doi: 10.1530/EJE-21-1228

Figure 3.

Figure 3

FFPE transcriptome classification and prognosis in the ACC validation cohort. (A) Samples projection based on the two principle components (Dim1 and Dim2) of the PCA performed based on the 2000 most variable genes in the 95 unique patients of the training cohort. Samples from the training cohort are presented as faint circles colored by transcriptome class. Samples from validation cohort are presented as full triangles colored by transcriptome class. (B) Disease-free survival according to the predicted transcriptome class in stage I–III ACC patients of the validation cohort. (C) Overall survival according to the predicted transcriptome class in stage I–IV ACC patients of the validation cohort.